Updated:
Form Life
FORM Life funds and incubates companies leveraging breakthrough science and technology to drive a new era in healthcare. The firm is led by Founding Partner...
Form Life
FORM Life funds and incubates companies leveraging breakthrough science and technology to drive a new era in healthcare. The firm is led by Founding Partner Markus Okumus and Scientific Founder Prof. Tony Wyss-Coray.
General information
Firm type
Private Equity
Year founded
2022
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Principals
Markus Okumus
Founding Partner
Tony Wyss-Coray
Scientific Founder
Vahik Soghom
Associate/IR
Sector focus
Frequently asked questions
Who runs investment decisions at Form Life?
Founding Partner Markus Okumus leads investment decisions, supported by Scientific Founder Tony Wyss-Coray. The firm lists Vahik Soghom as an Associate/IR, handling investor relations. No investment committee structure or advisory board has been publicly disclosed.
What investment stages does Form Life typically target?
Form Life focuses on the earliest stages: seed and startup. Its portfolio composition — companies still building core science and initial product-market fit — confirms a pre-Series A mandate. The firm does not list any growth-stage or late-stage holdings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: